TipRanks
Innate Pharma (DE:IDDA)
FRANKFURT:IDDA

Compare Innate Pharma (IDDA) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Innate Pharma
€1.73
€156.60M
-2.65
-26.47%
3 Buy
0 Hold
0 Sell
Strong Buy
SELLAS Life Sciences Group
$14.09
$2.49B
-53.98
570.41%
2 Buy
0 Hold
0 Sell
Moderate Buy
Elicio Therapeutics
$3.01
$47.83M
-0.91
-82.48%
2 Buy
1 Hold
0 Sell
Moderate Buy
Vor Biopharma
$24.01
$1.13B
-0.06
-54.00%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:IDDA
Innate Pharma
1.25
-0.48
-27.75%
SLS
SELLAS Life Sciences Group
11.33
9.62
562.57%
SGMO
―
―
―
―
GNFT
―
―
―
―
ELTX
Elicio Therapeutics
1.92
-9.15
-82.66%
VOR
Vor Biopharma
18.06
-18.62
-50.76%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts